Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. S.F. Oosting

Publications

Identification of new head and neck squamous cell carcinoma molecular imaging targets

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Nasopharyngeal carcinoma: nationwide trends in subtype-specific incidence and survival over 3 decades in a non-endemic area

Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function

Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastases

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to predict watchful waiting duration in patients with metastatic clear cell renal cell carcinoma

Abstract 5611: LAG-3 PET imaging in patients with cancer before immune checkpoint inhibitor therapy

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit

Read more

Press/media

Checklist Aims to Boost Quality of Life in Clinical Trials

Novel checklist for Quality of Life to bring ESMO-MCBS and clinical trials to the next level

Podcast over hoofd-hals-tumoren

Vaccino Covid: nei pazienti in chemioterapia buona risposta anticorpale

Many Patients With Solid Tumors Mount an Adequate Response to SARS–CoV-2 Vaccine, Dutch Study Reports

Most Solid Tumor Patients Have ‘Adequate’ Response to COVID-19 Vaccination, Regardless of Treatment

COVID-19 vaccination safe, effective during treatment for solid tumors

Read more